pillbase.ru

Increlex

Active substance: mecasermin

INJECTION · MECASERMIN 40 mg/4mL

United StatesActive

Marketing holder: Eton Pharmaceuticals, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Increlex
    Mecasermin
    EMEA/H/C/000704
    Esteve Pharmaceuticals, S.A.
Registration
Registration number
71863-216
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 71863-216 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 71863-216 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 71863-216 · Verified 2026-10-09 · open in source